Frequent methylprednisone pulse therapy is a risk factor for steroid cataracts in children

Pediatr Int. 2008 Aug;50(4):541-5. doi: 10.1111/j.1442-200X.2008.02629.x.

Abstract

Background: Pediatricians use corticosteroids for prolonged periods of time for the treatment of many diseases, including rheumatic disease. The side-effects of corticosteroids, especially cataracts, are widely recognized, but the predictive risk factors for steroid-induced cataracts have not yet been fully characterized.

Methods: The relationship between the formation of cataracts and steroid therapy was evaluated in patients with rheumatic disease.

Results: The initiation of steroid therapy in children under 12 years of age (P = 0.041) and i.v. methylprednisone pulse therapy (IVMP) (P = 0.046) are significant risk factors for inducing cataracts. In contrast, the cumulative corticosteroid dose, sex, and daily corticosteroid dose were not associated with cataract formation.

Conclusions: Younger children, who need frequent IVMP to treat their rheumatic diseases, should be examined by ophthalmologists frequently to avoid developing amblyopia from cataracts.

MeSH terms

  • Cataract / chemically induced
  • Child
  • Child, Preschool
  • Female
  • Glucocorticoids / administration & dosage*
  • Glucocorticoids / adverse effects*
  • Humans
  • Male
  • Prednisone / administration & dosage*
  • Prednisone / adverse effects*
  • Pulse Therapy, Drug
  • Rheumatic Diseases / drug therapy
  • Risk Factors

Substances

  • Glucocorticoids
  • Prednisone